Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01889 (
ankylosing spondylitis
)
5,717
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
cauda equina syndrome
in
ankylosing spondylitis
(the CES-AS syndrome) is marked by slow, insidious progression and a high incidence of dural ectasia in the lumbosacral spine. A high index of suspicion for this problem must be maintained when evaluating the patient with
ankylosing spondylitis
with a history of incontinence and neurologic deficit on examination. There has been disagreement in the literature as to whether surgical treatment is warranted for this condition. A meta-analysis was thus performed comparing outcomes with treatment regimens. Our results suggest that leaving these patients untreated or treating with steroids alone is inappropriate. Nonsteroidal antiinflammatory drugs may improve back pain but do not improve neurologic deficit. Surgical treatment of the dural ectasia, either by lumboperitoneal shunting or laminectomy, may improve neurologic dysfunction or halt the progression of neurologic deficit.
...
PMID:Cauda equina syndrome in ankylosing spondylitis (the CES-AS syndrome): meta-analysis of outcomes after medical and surgical treatments. 1158 43
A 62-year-old man suffering from long-standing
ankylosing spondylitis
had a 5-year history of progressive difficulty of defecation, micturition and erection, due to complication by a
cauda equina syndrome
.
...
PMID:[Diagnostic image (125). A man with Bechterew's disease and dysfunctional defecation, micturition and erection. Cauda equina syndrome]. 1262 80
A case of
ankylosing spondylitis
in a patient with a
cauda equina syndrome
is reported. A lumbar myelogram revealed erosions of the bones of the neural canal with enclosed multiple intraspinal cysts.
...
PMID:Ankylosing spondylitis: cauda equina syndrome with multiple spinal arachnoid cysts. Case report. 1476 94
Magnetic resonance imaging (MRI) is a valuable tool in the imaging and assessment of patients with
ankylosing spondylitis
. MRI can demonstrate the acute and chronic changes of sacroiliitis, osteitis, discovertebral lesions, disc calcifications and ossification and arthopathic lesions, which characterize the disease, as well as the complications, which include fracture and the rare
cauda equina syndrome
. This article reviews the range of MRI findings commonly seen within the axial skeleton in patients with this condition.
...
PMID:MRI of the axial skeletal manifestations of ankylosing spondylitis. 1564 8
Seronegative spondylarthritis are frequently characterised by extra-articular manifestations. They are frequently in recurrent uveitis. Between the cutaneous manifestations should be mentioned erythema nodosum, typical of inflammatory bowel diseases, and keratoderma blenorrhagicum, in the Reiter's syndrome. Cardiac complications in
ankylosing spondylitis
(AS) include aortic valvular regurgitation and arrhythmia and, more rarely, mitral valvulopathy, cardiomyopathy and pericarditis. Pulmonary involvement in AS includes ventilatory restrictive syndrome and fibro-bullous disease of the apex. Vertebral osteoporosis is a very important extra-articular manifestation because of the possibility of spontaneous fractures of the vertebrae. Central neurological manifestations include medullary compression from cervical sub-luxation while the most important peripheral involvements are lumbar stenosis and the
cauda equina syndrome
. Type AA amyloidosis is a rare late complication of the AS, possible cause of death especially in patients with aggressive disease. Kidney complications can be observed as consequences of prolonged anti-inflammatory therapy, but the most frequent renal complications are amyloidosis and mesangial IgA segmental and focal glomerulonephritis.
...
PMID:[Extra-articular manifestations of seronegative spondylarthritis]. 1683 61
The
cauda equina syndrome
(
CES
) is a rare neurological complication of
ankylosing spondylitis
(AS). Imaging diagnosis of
CES
in long-standing AS patients (CES-AS) using myelography, computed tomography (CT), and magnetic resonance imaging (MRI) were reported in the literature. They, however, demonstrate only the chronic abnormalities of
CES
-AS, i.e., dural ectasia, dorsal dural diverticula, and selective bone erosion at the posterior elements of the vertebrae. To our knowledge, imaging features of acute intradural inflammation in
CES
-AS were not described. We report a patient of
CES
-AS in whom MRI disclosed acute transverse myelitis and arachnoiditis along the lower spinal cord, and discuss the pathogenesis of
CES
-AS and the role of MRI in clinical management.
...
PMID:Combination of transverse myelitis and arachnoiditis in cauda equina syndrome of long-standing ankylosing spondylitis: MRI features and its role in clinical management. 1733 72
The
cauda equina syndrome
is an uncommon complication of long-standing
ankylosing spondylitis
and its aetiology is controversial. We report a case of the
cauda equina syndrome
, erosion of the posterior elements of the lumbar spine and traction of the lumbar nerve roots because of multiple dural diverticula in a patient with long-standing
ankylosing spondylitis
. Magnetic resonance imaging is valuable in excluding other spinal lesions. Extensive dural diverticula formation is characteristic of
ankylosing spondylitis
and has the potential to provide an early diagnosis.
...
PMID:Magnetic resonance imaging of cauda equina syndrome in long-standing ankylosing spondylitis. 1763 77
We present a 57-year-old man with
ankylosing spondylitis
(AS) and significant dorsal lumbar dural ectasia (diverticulum). An L5 nerve root monoradiculopathy associated with AS has not been previously reported. The quantity and extent of such ectasia is variable but may be related to
cauda equina syndrome
. Long-term follow-up of these cases may reveal whether or not solitary nerve lesions gradually lead to
cauda equina syndrome
. We recommend that asymptomatic or symptomatic patients with dural ectasia should be closely observed without need for immediate surgical intervention.
...
PMID:Lumbar radiculopathy in ankylosing spondylitis with dural ectasia. 1782 48
Neurological complications of
ankylosing spondylitis
(AS) are reported in 2.1% of patients.
Cauda equina syndrome
(
CES
) is rare and occurs at the ankylosing stage. MRI and CT of the lumbar spine show a cauda equina deformation with dural ectasia and bony erosion. We report three patients with AS presenting with progressive
CES
. These patients underwent lumboperitoneal shunting (LPS) surgery. The motor deficit improved in all cases. We suggest that
CES
develops from arterial pulsation of the CSF on a dural sac with reduced elasticity and that LPS reduces these intradural pressure shock waves. A meta-analysis by Ahn et al. [Ahn NU, Ahn UM, Nallamshetty L, et al.
Cauda equina syndrome
in
ankylosing spondylitis
(the
CES
-AS syndrome): meta-analysis of outcomes after medical and surgical treatments. J Spinal Disord 2001;14:427-33] concludes that surgical treatment has a better outcome than conservative or no treatment. Adding our 3 patients to this analysis, it appears that LPS for
CES
in AS is more efficient than laminectomy. LPS is a routine procedure for a rare indication, which promises improvement or atleast a stabilization of this disabling evolution of the disease.
...
PMID:Lumboperitoneal shunt for treatment of dural ectasia in ankylosing spondylitis. 1871 Aug 8
Cauda equina syndrome
is an uncommon complication of
ankylosing spondylitis
(AS) characterized by the slow and insidious development of severe neurologic impairment. Imaging studies usually show a wide lumbar canal with dural ectasia. No medical or surgical treatment has been proven effective. We managed the care of a 66-year-old man who had longstanding AS and clinical features of
cauda equina syndrome
, including anal incontinence and buttock hypoesthesia. Magnetic resonance imaging demonstrated no cause for these symptoms other than AS. The patient was treated with infliximab, a monoclonal antibody to tumor necrosis factor alpha that is used for the treatment of active AS. After 3 infliximab infusions, sphincter control and sensation were normal. The treatment was continued, and he was still doing well 1 year later. This is the first report of an effective treatment for
cauda equina syndrome
complicating AS. Our case report strongly supports an inflammatory mechanism to this condition.
...
PMID:Dramatic efficacy of infliximab in cauda equina syndrome complicating ankylosing spondylitis. 2017 29
<< Previous
1
2
3
4
5
6
Next >>